# OnCo record neeraj-agarwal (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/neeraj-agarwal/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "neeraj-agarwal" ;
  schema:name "Neeraj Agarwal"@en ;
  schema:description "GU oncologist who led TALAPRO-2 and other trials combining PARP inhibitors with hormone therapy."@en ;
  schema:url <https://onco.cc/people/neeraj-agarwal/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.swog.org/about/leadership>, <https://pubmed.ncbi.nlm.nih.gov/?term=Agarwal%20N%5BAuthor%5D>, <https://scholar.google.com/scholar?q=Neeraj%20Agarwal> ;
  schema:jobTitle "SWOG Executive Officer, Genitourinary and Early Therapeutics; Professor of Medicine, Huntsman Cancer Institute, University of Utah" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/rcc/> ;
  onco:targets <https://onco.cc/targets/parp/>, <https://onco.cc/targets/androgen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/talazoparib/> ;
  onco:companies <https://onco.cc/companies/swog/> ;
  onco:trials <https://onco.cc/trials/talapro-2/>, <https://onco.cc/trials/contact-03/> ;
  onco:journals <https://onco.cc/journals/future-oncology/> ;
  schema:affiliation <https://onco.cc/companies/swog/> .